How many years can esophagus cancer metaphase live

Update Date: 2023-02-27 Source: Network

summary

During this period of time, I always feel that there is something wrong with my throat, which is very uncomfortable. When I drink water, I feel very painful, and my voice is hoarse. I have symptoms of fever. I can't take medicine well. Patients with this disease should be treated as soon as possible. Now I will tell you about how many years can I live in the middle stage of esophageal cancer.

How many years can esophagus cancer metaphase live

First: the most important thing for the occurrence of diseases is to find them as soon as possible, so that they can be treated at the fastest speed and the best time. If patients can early detect esophageal cancer, the 5-year survival rate can reach 40% - 50%. In addition, they should actively accept treatment and choose the most favorable treatment for themselves.

Second: if esophageal cancer is found earlier, or early, the five-year survival rate is 50%! This is a common phenomenon, for early patients how long to live. If you want to live a few more years, choosing the right treatment is also the key. Patients with early esophageal cancer had better choose surgical treatment, and enhance the body's immunity, which is conducive to early recovery. The best choice for patients with advanced stage is the combination of traditional Chinese medicine and Western medicine, that is, radiotherapy and chemotherapy, supplemented by traditional Chinese medicine for conditioning, to promote the recovery of the body.

Third: a positive and optimistic attitude can also make patients with esophageal cancer live several years longer. Many patients are under great pressure after hearing about the disease, which is not conducive to the disease. Therefore, to maintain an optimistic and positive attitude is essential for patients.

matters needing attention

It's not terrible to get esophageal cancer. What's terrible is that patients lose their faith in life and their confidence in conquering this disease, which often affects the treatment of esophageal cancer and the rehabilitation of patients.